Increased Serum Pepsinogen I and Recurrence of Duodenal Ulcer
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 24 (10), 1200-1204
- https://doi.org/10.3109/00365528909090787
Abstract
To determine whether the serum pepsinogen I (PG I) level would be a suitable marker for selecting patients at risk for duodenal ulcer recurrence and, thus, would benefit from maintenance therapy, we treated duodenal ulcer patients with H2-receptor antagonists. After healing 140 ulcer patients we assessed the recurrence rate at 1 year with and without maintenance therapy. The annual recurrence rates in duodenal ulcer patients with hyper-PG I (95 ng/ml or more), with 66 ng/ml ± PG 1< 95 ng/ml, and with PG I < 66 ng/ml were 87.0%, 27.3%, and 17.9%, respectively, when they did not receive maintenace therapy. In patients with hyper-PG I the recurrence rate was significantly lower in patients receiving maintenance therapy than in patients not receiving maintenance therapy, whereas in patients with PG I< 66 ng/ml the recurrence rate was as low as 20% regardless of maintenance therapy. These results indicate that maintenance therapy with half the dose of H2-receptor antagonist is not required by patients with PG I < 66 ng/ml, whereas those with hyper-PG I may be good candidates for long-term maintenance therapy.Keywords
This publication has 25 references indexed in Scilit:
- Life events stress and psychosocial factors in men with peptic ulcer diseaseGastroenterology, 1988
- Recurrent Ulcer after Treatment with Cimetidine or SucralfateScandinavian Journal of Gastroenterology, 1987
- Nizatidine as Maintenance Therapy of Duodenal Ulcer Disease in RemissionScandinavian Journal of Gastroenterology, 1987
- Final Report on the United States Multicenter Trial Comparing Ranitidine to Cimetidine as Maintenance Therapy Following Healing of Duodenal UlcerJournal of Clinical Gastroenterology, 1985
- RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative TrialThe Lancet, 1984
- Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate?BMJ, 1982
- Genetic Heterogeneity of Hyperpepsinogenemic I and Normopepsinogenemic I Duodenal Ulcer DiseaseAnnals of Internal Medicine, 1979
- Serum Pepsinogen I, Serum Gastrin, and Gastric Acid Output in Postoperative Recurrent Peptic UlcerArchives of Surgery, 1978
- MAINTENANCE TREATMENT OF RECURRENT PEPTIC ULCER BY CIMETIDINEThe Lancet, 1978
- The Utility of the Blood Pepsin Assay in Clinical MedicineNew England Journal of Medicine, 1955